Dilip H. Bhuta reappointed as Whole Time Director and CFO for 5 years
JENBURPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shareholders at the 41st AGM approved the re-appointment of Shri Dilip H. Bhuta (74 years, DIN 03157252) as Whole Time Director and CFO for 5 years, from April 1, 2027 to March 31, 2032. Remuneration fixed for 3 years till March 31, 2030. He has been on the board since July 2013.
Continuity at the top. Existing CFO gets a fresh 5-year term, signaling stability in finance and operations leadership.